Compare NVDA & PM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVDA | PM |
|---|---|---|
| Founded | 1993 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1T | 266.5B |
| IPO Year | 1998 | 2007 |
| Metric | NVDA | PM |
|---|---|---|
| Price | $205.30 | $180.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 38 | 9 |
| Target Price | ★ $266.24 | $189.78 |
| AVG Volume (30 Days) | ★ 133.7M | 4.2M |
| Earning Date | 05-20-2026 | 04-22-2026 |
| Dividend Yield | 0.02% | ★ 3.61% |
| EPS Growth | ★ 66.67 | 60.62 |
| EPS | ★ 2.39 | 1.56 |
| Revenue | ★ $215,938,000,000.00 | $40,648,000,000.00 |
| Revenue This Year | $73.22 | $10.54 |
| Revenue Next Year | $31.16 | $6.65 |
| P/E Ratio | ★ $91.67 | $112.21 |
| Revenue Growth | ★ 65.47 | 7.31 |
| 52 Week Low | $140.86 | $142.11 |
| 52 Week High | $236.54 | $193.05 |
| Indicator | NVDA | PM |
|---|---|---|
| Relative Strength Index (RSI) | 43.29 | 51.83 |
| Support Level | $169.91 | $161.11 |
| Resistance Level | $214.37 | $191.78 |
| Average True Range (ATR) | 7.83 | 4.60 |
| MACD | -1.99 | -1.72 |
| Stochastic Oscillator | 1.20 | 37.53 |
Nvidia is a leading developer of graphics processing units. Traditionally, GPUs were used to enhance the experience on computing platforms, most notably in gaming applications on PCs. GPU use cases have since emerged as important semiconductors used in artificial intelligence to run large language models. Nvidia not only offers AI GPUs, but also a software platform, Cuda, used for AI model development and training. Nvidia is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads.
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets. It also owns the Veev brand in vapes.